Evaluation of Universal Antenatal Screening for Group B Streptococcus
Evaluation of Universal Antenatal Screening for Group B Streptococcus
复制标题
DOI：
10.1056/nejmoa0806820
复制
发表时间：
2009-06-18
影响因子：
158.5
通讯作者：
Schrag, Stephanie J.
中科院分区：
文献类型：
--
作者：
Van Dyke, Melissa K.;Phares, Christina R.;Schrag, Stephanie J.
背景B族链球菌病是出生后第一周内最常见的感染之一。在2002年，国家的指导方针建议普遍晚期产前筛查孕妇定植与组B链球菌，以确定候选人产时chemoproteination.MethodsWe评估的实施准则在一个多州，回顾性队列选择的活性细菌核心监测，10个国家，以人口为基础的系统，监测侵入性B链球菌疾病。我们从分层随机抽样的活产婴儿和所有新生儿早发性B组链球菌病（即，婴幼儿疾病
BackgroundGroup B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum chemoprophylaxis.MethodsWe evaluated the implementation of the guidelines in a multistate, retrospective cohort selected from the Active Bacterial Core surveillance, a 10-state, population-based system that monitors invasive group B streptococcal disease. We abstracted data from the labor and delivery records of a stratified random sample of live births and of all cases in which the newborn had early-onset group B streptococcal disease (i.e., disease in infants